Great West Life Assurance CO Editas Medicine, Inc. Transaction History

Great West Life Assurance CO

$57.4 Billion
Q3 2024

A detailed history of Great West Life Assurance CO transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 17,208 shares of EDIT stock, worth $23,747. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,208

Previous 20,077 14.29%

Holding current value

$23,747

Previous $93,000 36.56%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$3.39 - $5.96 $9,725 - $17,099	-2,869 Reduced 14.29%	17,208 $59,000
Q2 2024 Aug 12, 2024	SELL	$4.67 - $7.28 $109,422 - $170,577	-23,431 Reduced 53.85%	20,077 $93,000
Q1 2024 May 13, 2024	BUY	$7.03 - $11.07 $11,831 - $18,630	1,683 Added 4.02%	43,508 $322,000
Q4 2023 Feb 13, 2024	BUY	$6.25 - $11.11 $138,737 - $246,619	22,198 Added 113.1%	41,825 $421,000
Q3 2023 Nov 14, 2023	BUY	$6.92 - $9.31 $50,543 - $68,000	7,304 Added 59.27%	19,627 $153,000
Q2 2023 Aug 10, 2023	BUY	$6.36 - $11.47 $17,369 - $31,324	2,731 Added 28.47%	12,323 $101,000
Q1 2023 May 12, 2023	BUY	$7.03 - $11.53 $37,701 - $61,835	5,363 Added 126.81%	9,592 $69,000
Q4 2022 Feb 10, 2023	BUY	$8.32 - $13.21 $1,971 - $3,130	237 Added 5.94%	4,229 $38,000
Q3 2022 Nov 01, 2022	BUY	$12.16 - $19.42 $48,542 - $77,524	3,992 New	3,992 $48,000
Q2 2022 Aug 09, 2022	BUY	$9.99 - $21.35 $1,478 - $3,159	148 Added 3.99%	3,857 $46,000
Q1 2022 May 12, 2022	BUY	$14.08 - $27.63 $1,703 - $3,343	121 Added 3.37%	3,709 $75,000
Q4 2021 Feb 14, 2022	BUY	$26.55 - $40.57 $3,026 - $4,624	114 Added 3.28%	3,588 $95,000
Q2 2021 Aug 11, 2021	SELL	$31.29 - $56.64 $21,683 - $39,251	-693 Reduced 16.63%	3,474 $197,000
Q3 2020 Nov 17, 2020	SELL	$28.06 - $37.16 $201,049 - $266,251	-7,165 Reduced 63.23%	4,167 $116,000
Q3 2020 Nov 13, 2020	BUY	$28.06 - $37.16 $201,049 - $266,251	7,165 Added 171.95%	11,332 $317,000
Q2 2020 Aug 17, 2020	BUY	$18.5 - $34.34 $22,144 - $41,104	1,197 Added 40.3%	4,167 $123,000
Q4 2019 Feb 11, 2020	BUY	$19.49 - $32.63 $29,546 - $49,467	1,516 Added 104.26%	2,970 $87,000
Q3 2019 Oct 25, 2019	SELL	$22.49 - $26.81 $88,430 - $105,416	-3,932 Reduced 73.0%	1,454 $33,000
Q2 2019 Jul 31, 2019	BUY	$20.48 - $27.76 $20,152 - $27,315	984 Added 22.35%	5,386 $0
Q4 2018 Feb 12, 2019	SELL	$18.19 - $31.79 $407,692 - $712,509	-22,413 Reduced 83.58%	4,402 $97,000
Q3 2018 Nov 13, 2018	SELL	$27.65 - $38.39 $725,536 - $1.01 Million	-26,240 Reduced 49.46%	26,815 $856,000
Q2 2018 Aug 10, 2018	BUY	$31.4 - $41.01 $102,018 - $133,241	3,249 Added 6.52%	53,055 $1.9 Million
Q1 2018 May 10, 2018	BUY	$29.84 - $44.08 $1.34 Million - $1.98 Million	44,847 Added 904.36%	49,806 $1.65 Million
Q3 2017 Nov 09, 2017	BUY	$15.81 - $24.01 $78,401 - $119,065	4,959	4,959 $114,000

Others Institutions Holding EDIT

# of Institutions

250

Shares Held

56.9M

Call Options Held

410K

Put Options Held

394K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $94.9M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Editas Medicine, Inc. Transaction History